{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:17:19Z","timestamp":1791296239303,"version":"4.1.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the new World Health Organization\/European Organization for Research and Treatment of Cancer (WHO\/EORTC) classification of cutaneous lymphomas, large B-cell lymphomas (LBCLs) are divided into 3 groups: LBCL, leg-type (LBCLLT); follicle center lymphoma, diffuse type (FCLDT); and LBCL, others (LBCLO). We studied a large number of primary cutaneous LBCLs to test the validity of the classification and to identify prognostic factors for these patients. Ninety-three cases of primary cutaneous LBCL were analyzed for clinicopathologic features, expression of several markers including Bcl-2, Bcl-6, MUM-1, and FOX-P1, in situ hybridization for Epstein-Barr virus, and molecular analyses of IGH gene rearrangement and of Borrelia burgdorferi and human herpesvirus 8 DNA. Patients were classified into the following categories: FCLDT, 44 cases; LBCLLT, 40 cases; and LBCLO, 9 cases. Statistical analyses showed that the LBCLLT and FCLDT groups were clearly distinct in terms of clinicopathologic features and survival. The LBCLO group had features in between those of LBCLLT and FCLDT. Our study shows that accurate morphologic and phenotypic analyses allow us to stratify most patients into the prognostically different categories of LBCLLT and FCLDT. The definition of a third category of LBCLO requires further studies to clarify whether these cases indeed show distinct clinicopathologic features. (Blood. 2005;106:2491-2497)<\/jats:p>","DOI":"10.1182\/blood-2005-03-1175","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T20:34:33Z","timestamp":1118349273000},"page":"2491-2497","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":201,"title":["Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients"],"prefix":"10.1182","volume":"106","author":[{"given":"Kazuo","family":"Kodama","sequence":"first","affiliation":[{"name":"From the Departments of Dermatology, Medical University, Graz, Austria; Hokkaido University, Sapporo, Japan; University of Mu\u0308nster, Mu\u0308nster, Germany; and Department of Pathology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Massone","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Medical University, Graz, Austria; Hokkaido University, Sapporo, Japan; University of Mu\u0308nster, Mu\u0308nster, Germany; and Department of Pathology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Chott","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Medical University, Graz, Austria; Hokkaido University, Sapporo, Japan; University of Mu\u0308nster, Mu\u0308nster, Germany; and Department of Pathology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Metze","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Medical University, Graz, Austria; Hokkaido University, Sapporo, Japan; University of Mu\u0308nster, Mu\u0308nster, Germany; and Department of Pathology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Kerl","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Medical University, Graz, Austria; Hokkaido University, Sapporo, Japan; University of Mu\u0308nster, Mu\u0308nster, Germany; and Department of Pathology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cerroni","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Medical University, Graz, Austria; Hokkaido University, Sapporo, Japan; University of Mu\u0308nster, Mu\u0308nster, Germany; and Department of Pathology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218471531000_REF1","doi-asserted-by":"crossref","unstructured":"Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood.2005;105: 3768-3785.","DOI":"10.1182\/blood-2004-09-3502"},{"key":"2020021218471531000_REF2","unstructured":"Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 171-177."},{"key":"2020021218471531000_REF3","unstructured":"Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood.1997;90: 354-371."},{"key":"2020021218471531000_REF4","doi-asserted-by":"crossref","unstructured":"Fink-Puches R, Zenahlik P, Back B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood.2002;99: 800-805.","DOI":"10.1182\/blood.V99.3.800"},{"key":"2020021218471531000_REF5","doi-asserted-by":"crossref","unstructured":"Barrans SL, Fenton JAL, Banham A, Owen RG, Jack AS. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood.2004;104: 2933-2935.","DOI":"10.1182\/blood-2004-03-1209"},{"key":"2020021218471531000_REF6","doi-asserted-by":"crossref","unstructured":"Cerroni L, Zo\u0308chling N, Pu\u0308tz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol.1997;24: 457-461.","DOI":"10.1111\/j.1600-0560.1997.tb01318.x"},{"key":"2020021218471531000_REF7","doi-asserted-by":"crossref","unstructured":"Colli C, Leinweber B, Mu\u0308llegger R, Chott A, Kerl H, Cerroni L. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol.2004;31: 232-240.","DOI":"10.1111\/j.0303-6987.2003.00167.x"},{"key":"2020021218471531000_REF8","doi-asserted-by":"crossref","unstructured":"Zo\u0308chling N, Pu\u0308tz B, Wolf P, Kerl H, Cerroni L. Human herpesvirus 8-specific DNA sequences in primary cutaneous B-cell lymphomas. Arch Dermatol.1998;134: 246-247.","DOI":"10.1001\/archderm.134.2.246"},{"key":"2020021218471531000_REF9","doi-asserted-by":"crossref","unstructured":"Wienecke R, Neubert U, Volkenandt R. Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffin-embedded lesions of Lyme disease. J Cutan Pathol.1993;20: 385-388.","DOI":"10.1111\/j.1600-0560.1993.tb00658.x"},{"key":"2020021218471531000_REF10","doi-asserted-by":"crossref","unstructured":"Rosa PA, Hogan D, Schwan TG. Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol.1991;29: 524-532.","DOI":"10.1128\/JCM.29.3.524-532.1991"},{"key":"2020021218471531000_REF11","doi-asserted-by":"crossref","unstructured":"Chang Y, Cesarman E, Pessin M, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science.1996;266: 1865-1869.","DOI":"10.1126\/science.7997879"},{"key":"2020021218471531000_REF12","doi-asserted-by":"crossref","unstructured":"Monini P, Lellis L, Fabris M, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med.1996;334: 1168-1172.","DOI":"10.1056\/NEJM199605023341805"},{"key":"2020021218471531000_REF13","doi-asserted-by":"crossref","unstructured":"Wan JH, Trainor KJ, Brisco MJ, et al. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol.1990;43: 888-890.","DOI":"10.1136\/jcp.43.11.888"},{"key":"2020021218471531000_REF14","doi-asserted-by":"crossref","unstructured":"Grange F, Bekkenk MW, Wechsler J, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol.2001;19: 3602-3610.","DOI":"10.1200\/JCO.2001.19.16.3602"},{"key":"2020021218471531000_REF15","doi-asserted-by":"crossref","unstructured":"Grange F, Petrella T, Beylot-Barry M, et al. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood.2004;103: 3662-3668.","DOI":"10.1182\/blood-2003-08-2726"},{"key":"2020021218471531000_REF16","doi-asserted-by":"crossref","unstructured":"Fernandez-Vazquez A, Rodriguez-Peralto JL, Martinez MA, et al. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival. Am J Surg Pathol.2001;25: 307-315.","DOI":"10.1097\/00000478-200103000-00004"},{"key":"2020021218471531000_REF17","doi-asserted-by":"crossref","unstructured":"Goodlad JR, Krajewski AS, Batstone PJ, et al. Primary cutaneous diffuse large B-cell lymphoma. Prognostic significance of clinicopathological subtypes. Am J Surg Pathol.2003;27: 1538-1545.","DOI":"10.1097\/00000478-200312000-00006"},{"key":"2020021218471531000_REF18","doi-asserted-by":"crossref","unstructured":"Vermeer MH, Geelen FA, van Haselen CW, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol.1996;132: 1304-1308.","DOI":"10.1001\/archderm.1996.03890350042008"},{"key":"2020021218471531000_REF19","doi-asserted-by":"crossref","unstructured":"Geelen FA, Vermeer MH, Meijer CJ, et al. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol.1998;16: 2080-2085.","DOI":"10.1200\/JCO.1998.16.6.2080"},{"key":"2020021218471531000_REF20","doi-asserted-by":"crossref","unstructured":"Paulli M, Viglio A, Vivenza D, et al. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity. Hum Pathol.2002;33: 937-943.","DOI":"10.1053\/hupa.2002.126881"},{"key":"2020021218471531000_REF21","unstructured":"Banham A, Brown P, Baldry C, Ott G. Expression of the FOXP1 transcription factor is stronger in activated B-like diffuse large B cell lymphomas [abstract]. J Clin Pathol.2002;55(suppl 1): 28."},{"key":"2020021218471531000_REF22","doi-asserted-by":"crossref","unstructured":"Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood.2004;103: 275-282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"2020021218471531000_REF23","unstructured":"Brown PJ, Banham AH, Connors JM, et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma [abstract]. Blood2003;102: 102a."},{"key":"2020021218471531000_REF24","doi-asserted-by":"crossref","unstructured":"Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A.1998;95: 11816-11821.","DOI":"10.1073\/pnas.95.20.11816"},{"key":"2020021218471531000_REF25","doi-asserted-by":"crossref","unstructured":"Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science.1998;280: 1750-1752.","DOI":"10.1126\/science.280.5370.1750"},{"key":"2020021218471531000_REF26","doi-asserted-by":"crossref","unstructured":"Dogan A, Bagdi E, Munson P, Isaacson PG. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol.2000;24: 846-852.","DOI":"10.1097\/00000478-200006000-00010"},{"key":"2020021218471531000_","doi-asserted-by":"crossref","unstructured":"King BE, Chen C, Locker J, et al. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. Mod Pathol.2000;13: 1219-1231.","DOI":"10.1038\/modpathol.3880226"},{"key":"2020021218471531000_","doi-asserted-by":"crossref","unstructured":"Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med.1999;341: 1520-1529.","DOI":"10.1056\/NEJM199911113412007"},{"key":"2020021218471531000_REF29","doi-asserted-by":"crossref","unstructured":"Ree HJ, Yang WI, Kim CW, et al. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma. Hum Pathol.2001;32: 954-962.","DOI":"10.1053\/hupa.2001.27118"},{"key":"2020021218471531000_REF30","doi-asserted-by":"crossref","unstructured":"Hoefnagel JJ, Vermeer MH, Jansen PM, Fleuren GJ, Meijer CJ, Willemze R. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol.2003;149: 1183-1191.","DOI":"10.1111\/j.1365-2133.2003.05649.x"},{"key":"2020021218471531000_REF31","doi-asserted-by":"crossref","unstructured":"Sundram U, Kim Y, Mraz-Gernhard S, Hoppe R, Natkunam Y, Kohler S. Expression of the bcl-6 and MUM1\/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. J Cutan Pathol.2005;32: 227-234.","DOI":"10.1111\/j.0303-6987.2005.00298.x"},{"key":"2020021218471531000_REF32","unstructured":"Chang Y, Moore PS. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis.1996;5: 215-222."},{"key":"2020021218471531000_REF33","doi-asserted-by":"crossref","unstructured":"Nador RG, Milligan LL, Flore O, et al. Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas. Virology.2001;287: 62-70.","DOI":"10.1006\/viro.2001.1016"},{"key":"2020021218471531000_REF34","doi-asserted-by":"crossref","unstructured":"Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood.1996;88: 3124-3128.","DOI":"10.1182\/blood.V88.8.3124.bloodjournal8883124"},{"key":"2020021218471531000_REF35","unstructured":"Duray PH, Pincus G, Jaffe ES. B-cell lymphoma associated with Borrelia burgdorferi infection in the United States [abstract]. Mod Pathol.2000;13: 147."},{"key":"2020021218471531000_REF36","doi-asserted-by":"crossref","unstructured":"Goodlad JR, Davidson MM, Hollowood K, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the high-lands of Scotland. Am J Surg Pathol.2000;24: 1279-1285.","DOI":"10.1097\/00000478-200009000-00012"},{"key":"2020021218471531000_REF37","unstructured":"Park JP, Curran MJ, Levy NB, Davis TH, Elliott JH, Mohandas TK. Diffuse large cell, B-cell type lymphoma with a novel translocation (2;22)(p23; q11.2). Cancer Genet Cytogenet.1997;96: 118-122."},{"key":"2020021218471531000_REF38","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature.2000;403: 503-511.","DOI":"10.1038\/35000501"},{"key":"2020021218471531000_REF39","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Wright G, Chan WC, et al. Lymphoma\/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med.2002;346: 1937-1947.","DOI":"10.1056\/NEJMoa012914"},{"key":"2020021218471531000_REF40","doi-asserted-by":"crossref","unstructured":"Storz MN, van de Rijn M, Kim YH, Mraz-Gernhard S, Hoppe RT, Kohler S. Gene expression profiles of cutaneous B cell lymphoma. J Invest Dermatol.2003;120: 865-870.","DOI":"10.1046\/j.1523-1747.2003.12142.x"},{"key":"2020021218471531000_REF41","doi-asserted-by":"crossref","unstructured":"Hoefnagel JJ, Dijkman R, Basso K, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood.2005;105: 3671-3678.","DOI":"10.1182\/blood-2004-04-1594"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/7\/2491\/1635282\/zh801905002491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/7\/2491\/1635282\/zh801905002491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T11:56:05Z","timestamp":1586260565000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/7\/2491\/21693\/Primary-cutaneous-large-Bcell-lymphomas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-03-1175","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10072.467556","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}